Outpatient parenteral antibacterial therapy: myths and reality

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The article is devoted to a new hospital-replacing technology – outpatient parenteral antibacterial therapy (APAT). The indications, contraindications, techniques and clinical effectiveness of APAT are discussed in detail. The benefits of APAT are realized when time-dependent antimicrobial agents are prescribed. Consistent drug delivery is achieved through the use of elastomeric pumps. The use of APAT increases patients' motivation for treatment and reduces the burden on medical staff. The introduction of APAT, in addition to clinical benefits, contributes to significant savings in the financial resources of a medical institution.

Full Text

Restricted Access

About the authors

I. N. Pasechnik

Central State Medical Academy of Department of Presidential Affairs

Author for correspondence.
Email: pasigor@yandex.ru
ORCID iD: 0000-0002-8121-4160

MD, Professor

Russian Federation, Moscow

S. V. Krylov

Central State Medical Academy of Department of Presidential Affairs; N.N. Priorov Central Institute for Trauma and Orthopedics

Email: pasigor@yandex.ru
ORCID iD: 0000-0001-7755-7163

PhD

Russian Federation, Moscow; Moscow

D. V. Martynov

Rostov State Medical University, Ministry of Health of Russia

Email: pasigor@yandex.ru
ORCID iD: 0000-0003-3644-5274

PhD, Associate Professor

Russian Federation, Rostov-on-Don

References

  1. Пасечник И.Н. Программа ускоренного выздоровления после хирургических вмешательств: мультидисциплинарный подход и организационные проблемы. Заместитель главного врача. 2016; 4: 20–7 [Pasechnik I.N. Program of accelerated recovery after surgical interventions: multidisciplinary approach and organizational problems. Zamestitel' glavnogo vracha. 2016; 4: 20–7 (in Russ.)].
  2. Затевахин И.И., Пасечник И.Н. Программа ускоренного выздоровления в хирургии (FAST TRACK) внедрена. Что дальше? Вестник хирургии им. И.И. Грекова. 2018; 177 (3): 70–5 [Zatevachin I.I., asechnik I.N. The program of accelerated recovery in surgery (fast trak) has been introduced. Wgat’s the next? Grekov's Bulletin of Surgery. 2018; 177 (3): 70–5 (in Russ.)]. doi: 10.24884/0042-4625-2018-177-3-70-75
  3. Егоров Д.В., Лазарева Ю.А., Селиверстов П.В. Подходы к ведению пациентов хирургического профиля с антибиотик-ассоциированной диареей легкого течения. Медицинский Совет. 2023; 18: 128–33 [Egorov D.V., Lazareva Yu.A., Seliverstov P.V. Approaches to the management of surgical patients with antibiotic-associated mild diarrhea. Medical Council. 2023; 18: 128–33 (in Russ.)]. doi: 10.21518/ms2023-385
  4. Johnson T.M., Webster L.C.W., Mehta M. et al. Pushing the agenda for intravenous push administration in outpatient parenteral antimicrobial therapy. Ther Adv Infect Dis. 2023; 10: 20499361231193920. doi: 10.1177/20499361231193920
  5. Norris A.H., Shrestha N.K., Allison G.M. et al. 2018 Infectious Diseases Society of America Clinical Practice Guideline for the Management of Outpatient Parenteral Antimicrobial Therapy. Clin Infect Dis. 2019; 68 (1): e1–35. doi: 10.1093/cid/CIY745
  6. Chapman A.L.N., Patel S., Horner C. et al. Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK. JAC Antimicrob Resist. 2019; 1 (2): dlz026. doi: 10.1093/jacamr/dlz026
  7. National Home Infusion Association. NHIF infusion industry trends report. URL: https://nhia.org/nhif/nhif_infusion_industry_trends_report
  8. Fortune Business Insights. U.S. home infusion therapy market size, share and COVID-19 impact analysis, by product (devices, drugs, and services), by indication (anti-infective, chemotherapy, hydration therapy, enteral nutrition, total parenteral nutrition, immunoglobulins, and others), and forecast, 2021–2028. URL: https:/www.fortunebusinessinsights.com/u-s-home-infusion-therapy-market-106327
  9. Rucker R.W., Harrison G.M. Outpatient intravenous medications in the management of cystic fibrosis. Pediatrics. 1974; 54 (3): 358–60.
  10. Williams D.N., Baker C.A., Kind A.C. et al. The history and evolution of outpatient parenteral antibiotic therapy (OPAT). Int J Antimicrob Agents. 2015; 46 (3): 307–12. doi: 10.1016/j.ijantimicag.2015.07.001
  11. Mahoney M.V., Childs-Kean L.M., Khan P. et al. Recent Updates in Antimicrobial Stewardship in Outpatient Parenteral Antimicrobial Therapy. Curr Infect Dis Rep. 2021; 23 (12): 24. doi: 10.1007/s11908-021-00766-x
  12. Loriaux A., Desmond M., Li P.C. A Primer on Home Infusion Administration Methods. Open Forum Infect Dis. 2022; 9 (12): ofac525. doi: 10.1093/ofid/ofac525
  13. Cassettari V., Novato N., Onuchic M.H.F. Antimicrobial stewardship in the outpatient parenteral antimicrobial therapy (OPAT) setting: the impact of prescription assessment by an infectious diseases specialist. Braz J Infect Dis. 2021; 25 (2): 101560. doi: 10.1016/j.bjid.2021.101560
  14. Wang W. Tolerability of hypertonic injectables. Int J Pharm. 2015; 490 (1-2): 308–15. doi: 10.1016/j.ijpharm.2015.05.069
  15. Loeuille G., D'Huart E., Vigneron J. et al. Stability Studies of 16 Antibiotics for Continuous Infusion in Intensive Care Units and for Performing Outpatient Parenteral Antimicrobial Therapy. Antibiotics (Basel). 2022; 11 (4): 458. doi: 10.3390/antibiotics11040458
  16. Rodriguez-Martinez L., Castro-Balado A., Hermelo-Vidal G. et al. Ampicillin Stability in a Portable Elastomeric Infusion Pump: A Step Forward in Outpatient Parenteral Antimicrobial Therapy. Pharmaceutics. 2023; 15 (8): 2099. doi: 10.3390/pharmaceutics15082099
  17. Voumard R., Gardiol C., André P. et al. Efficacy and safety of continuous infusions with elastomeric pumps for outpatient parenteral antimicrobial therapy (OPAT): an observational study. J Antimicrob Chemother. 2018; 73 (9): 2540–5. doi: 10.1093/jac/dky224
  18. Thijs L., Quintens C., Vander Elst L. et al. Clinical Efficacy and Safety of Vancomycin Continuous Infusion in Patients Treated at Home in an Outpatient Parenteral Antimicrobial Therapy Program. Antibiotics (Basel). 2022; 11 (5): 702. doi: 10.3390/antibiotics11050702
  19. Poole S.M., Nowobilski-Vasilios A., Free F. Intravenous push medications in the home. J Intraven Nurs. 1999; 22 (4): 209–15.
  20. Hamad Y., Dodda S., Frank A. et al. Perspectives of Patients on Outpatient Parenteral Antimicrobial Therapy: Experiences and Adherence. Open Forum Infect Dis. 2020; 7 (6): ofaa205. doi: 10.1093/ofid/ofaa205
  21. Пасечник И.Н., Рыбинцев В.Ю., Талызин П.А. Безопасность фармакотерапии: что нового? Анестезиология и реаниматология. 2019; 5: 47–50 [Pasechnik I.N., Rybintsev V.Yu., Talyzin P.A. Safety of pharmacotherapy: what's new? Russian Journal of Anesthesiology and Reanimatology. 2019; 5: 47–50 (in Russ.)]. DOI.: 10.17116/anaesthesiology201905147
  22. Staples J.A., Ho M., Ferris D. et al. Outpatient Versus Inpatient Intravenous Antimicrobial Therapy: A Population-Based Observational Cohort Study of Adverse Events and Costs. Clin Infect Dis. 2022; 75 (11): 1921–9. doi: 10.1093/cid/ciac298
  23. Farmer E.C.W., Seaton R.S. Recent innovations and new applications of outpatient parenteral antimicrobial therapy. Expert Rev Anti Infect Ther. 2021; 19 (1): 55–64. doi: 10.1080/14787210.2020.1810566
  24. Mackintosh C.L., White H.A., Seaton R.A. Outpatient parenteral antibiotic therapy (OPAT) for bone and joint infections: experience from a UK teaching hospital-based service. J Antimicrob Chemother. 2011; 66 (2): 408–15. doi: 10.1093/jac/dkq445
  25. Kutubi A., O'Brien L., Murphy B. et al. A single centre experience of prosthetic joint infection outcomes with outpatient parenteral antimicrobial therapy. Heliyon. 2023; 9 (4): e15212. doi: 10.1016/j.heliyon.2023.e15212
  26. Rezar R., Lichtenauer M., Haar M. et al. Infective endocarditis – A review of current therapy and future challenges. Hellenic J Cardiol. 2021; 62 (3): 190–200. doi: 10.1016/j.hjc.2020.10.007
  27. Rajaratnam D., Rajaratnam R. Outpatient Parenteral Antimicrobial Therapy for Infective Endocarditis-Model of Care. Antibiotics (Basel). 2023; 12 (2): 355. doi: 10.3390/antibiotics12020355
  28. Cahill T.J., Baddour L.M., Habib G. et al. Challenges in Infective Endocarditis. J Am Coll Cardiol. 2017; 69 (3): 325–44. doi: 10.1016/j.jacc.2016.10.066
  29. Fink D.L., Collins S., Barret R. et al. Shortening duration of ertapenem in outpatient parenteral antimicrobial therapy for complicated urinary tract infections: A retrospective study. PLoS One. 2019; 14 (9): e0223130. doi: 10.1371/journal.pone.0223130
  30. Ponce González M.A., Mirón Rubio M., Mujal Martinez A. et al. Effectiveness and safety of outpatient parenteral antimicrobial therapy in acute exacerbation of chronic obstructive pulmonary disease. Int J Clin Pract. 2017; 71 (12). doi: 10.1111/ijcp.13022
  31. Castillo-Fernández N., Pérez-Crespo P.M.M., Salamanca-Rivera E. et al. Conventional Hospitalization versus Sequential Outpatient Parenteral Antibiotic Therapy for Staphylococcus aureus Bacteremia: Post-Hoc Analysis of a Multicenter Observational Cohort. Antibiotics (Basel). 2023; 12 (1): 129. doi: 10.3390/antibiotics12010129
  32. Carter B., Fisher-Smith D., Porter D. et al. Paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): An e-survey of the experiences of parents and clinicians. PLoS One. 2021; 16 (4): e0249514. doi: 10.1371/journal.pone.0249514

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Elastic pump by Woo Young Medical Co., Ltd.

Download (403KB)
Indexing metadata

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies